ANTIBODIES WITH MODULATED GLYCAN PROFILES

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20240384238A1
SERIAL NO

18779687

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to recombinantly-expressed denosumab molecules and methods for modulating glycan profiles of denosumab molecules.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMGEN INCONE AMGEN CENTER DRIVE M/S 28-2-C THOUSAND OAKS CA 91320

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BRANDENSTEIN, Michael Charles Woodinville, US 8 7
CROWELL, Christopher Kenyon Thousand Oaks, US 9 0
GILLESPIE, Alison Jean Seattle, US 2 0
KITCHEN, Neil Alberta, CA 2 0
Nagi, Athena Denise Souderton, US 2 0
PETROVAN, Simina Crina Lynnwood, US 8 7
WU, Jian Acton, US 427 2508

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation